| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |